Manchester-headquartered molecular diagnostics company and Seneca EIS Portfolio company Premaitha Health has appointed Barry Hextall as the new chief financial officer to replace Mark Collingbourne with immediate effect.
David Evans, chairman of Premaitha, said: “On behalf of the board, I welcome Barry to the team at this exciting time for Premaitha as the company grows sales of its non-invasive prenatal screening test, IONA. Barry’s long-term experience as a CFO, especially his knowledge of the AIM market and diagnostics sector, will be invaluable to us as we continue our strategy for growth in Europe.”
See the article in full at InsiderMedia.com